{"schema_version":"alpha-profile-public-v1","slug":"anthony-p-adamis-m-d","canonical_url":"https://registry.alpha.ac/people/anthony-p-adamis-m-d","as_of":"2026-09-21T17:53:54.526794+00:00","published_at":"2026-09-02T02:37:20.858652+00:00","last_reviewed_at":"2026-05-01T02:20:50.556+00:00","identity":{"display_name":"Anthony P. Adamis, M.D.","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive","board"],"current_role":{"company_name":"Kalaris Therapeutics, Inc.","company_slug":"kalaris-therapeutics-inc","exchange":"NASDAQ","ticker":"KLRS","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","effective_date":"2026-04-24","last_checked_at":"2026-04-24T23:29:01.172+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=anthony-p-adamis-m-d","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=anthony-p-adamis-m-d&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Dr. Adamis is a renowned ophthalmology scientist best known for co-discovering the central role of VEGF in neovascular age-related macular degeneration and diabetic retinopathy, research that earned him the Antonio Champalimaud Award and election to the National Academy of Medicine. He currently serves as Chief Scientific Officer of EyeBio, a Merck subsidiary, and previously held senior roles at Genentech and co-founded Eyetech Pharmaceuticals. Over his career he has helped develop 20 medicines across 30 indications resulting in 32 FDA approvals."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Kalaris Therapeutics, Inc.","organizationId":"kalaris-therapeutics-inc","title":"Director","period":"2025-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Kalaris Therapeutics, Inc.","company_slug":"kalaris-therapeutics-inc","exchange":"NASDAQ","ticker":"KLRS","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2025-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","effective_date":"2026-04-24","last_checked_at":"2026-04-24T23:29:01.172+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Anthony P. Adamis, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:50.7766+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:50.64306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_membership","claim_value":{"ticker":"KLRS","role_type":"Director","organization":"Kalaris Therapeutics, Inc."},"claim_text":"Serves on the board of Kalaris Therapeutics, Inc. as Director.","claim_state":"verified","valid_from":"2025-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.999553+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Kalaris Therapeutics, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Director","claim_text":"Anthony P. Adamis, M.D. currently serves as Director at Kalaris Therapeutics, Inc..","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:50.721086+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:50.64306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Audit"],"claim_text":"Anthony P. Adamis, M.D. serves on Audit.","claim_state":"verified","valid_from":"2026-04-24","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:50.754316+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:50.64306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":{"committees":["Audit"]},"claim_text":"Committee assignments at Kalaris Therapeutics, Inc.: Audit.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.999553+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Kalaris Therapeutics, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Eyebiotech Limited (EyeBio), a subsidiary of Merck & Co., Inc.","claim_text":"Anthony P. Adamis, M.D. is linked to Eyebiotech Limited (EyeBio), a subsidiary of Merck & Co., Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:50.893628+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:50.64306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Scientific Officer","claim_text":"Anthony P. Adamis, M.D. is also listed as Chief Scientific Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:50.874572+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:50.64306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Anthony P. Adamis, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:50.816435+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:50.64306+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"director_since","claim_value":{"start_date":null,"director_since":2025},"claim_text":"Director tenure at Kalaris Therapeutics, Inc. begins from 2025.","claim_state":"verified","valid_from":"2025-01-01","valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.999553+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Kalaris Therapeutics, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"independence_status","claim_value":{"is_independent":true},"claim_text":"Board independence status at Kalaris Therapeutics, Inc.: True.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.95,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-03T01:56:42.999553+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"Kalaris Therapeutics, Inc. director board source","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-03T01:47:45.110153+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Anthony P. Adamis, M.D. as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-01T02:20:50.796712+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"KLRS DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","published_at":"2026-04-24T00:00:00+00:00","last_checked_at":"2026-05-01T02:20:50.64306+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:anthony-p-adamis-m-d","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2025-01-01 · current","organization":"Kalaris Therapeutics, Inc.","organization_id":"kalaris-therapeutics-inc"},"claim_text":"Director at Kalaris Therapeutics, Inc. (2025-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/anthony-p-adamis-m-d#profile","url":"https://registry.alpha.ac/people/anthony-p-adamis-m-d","dateModified":"2026-05-01T02:20:50.556+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/anthony-p-adamis-m-d#person","name":"Anthony P. Adamis, M.D.","url":"https://registry.alpha.ac/people/anthony-p-adamis-m-d","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Kalaris Therapeutics, Inc.","tickerSymbol":"NASDAQ: KLRS"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2025-01-01","memberOf":{"@type":"Organization","name":"Kalaris Therapeutics, Inc.","url":"https://registry.alpha.ac/companies/kalaris-therapeutics-inc","tickerSymbol":"NASDAQ: KLRS"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1754068/000119312526177362/d113973ddef14a.htm","name":"KLRS DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/anthony-p-adamis-m-d"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":10,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":11,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":4,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"corroborated","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":10,"corroborated":1,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"At least one published claim is corroborated by two or more public sources. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":11,"corroborated_claims":1,"sources":4,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-01T02:20:50.556+00:00","observed_at":"2026-09-21T17:53:54.526794+00:00","freshness_days":144}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"anthony-p-adamis-m-d","canonical_url":"https://registry.alpha.ac/people/anthony-p-adamis-m-d"},"publication":{"published_at":"2026-09-02T02:37:20.858652+00:00","last_reviewed_at":"2026-05-01T02:20:50.556+00:00","as_of":"2026-09-21T17:53:54.526794+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/anthony-p-adamis-m-d","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/anthony-p-adamis-m-d","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/anthony-p-adamis-m-d.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}